Monthly Archives: December 2019

JANUARY 2 FINAL DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sealed Air Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 28, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sealed Air Corporation ("Sealed Air" or "the Company") (NYSE:SEE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission."

Investors who purchased the Company's securities between November 5, 2014 and August 6, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before December 31, 2019.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Sealed Air improperly deducted $1.49 billion related to the settlement of asbestos liabilities from its taxes to artificially inflate its financial performance. The Company switched auditors to help facilitate this fraud. On August 6, 2018, the Company admitted that it had received a subpoena from the SEC related to the Company's accounting for taxes and financial disclosures. Based on these facts, the company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Sealed Air, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 571552

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Exelon Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 28, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Exelon Corporation ("Exelon" or "the Company") (NASDAQ:EXC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between February 9, 2019 and November 1, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before February 14, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Exelon and its employees engaged in improper lobbying of government officials. These actions increased the likelihood of a criminal investigation of the Company. Exelon subsidiary Commonwealth Edison gained revenues as a result of the improper conduct which would be unsustainable in the future. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Exelon, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 571553

INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mattel, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 28, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mattel, Inc. ("Mattel" or "the Company") (NASDAQ:MAT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between October 26, 2017 and August 8, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before February 24, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Mattel failed to maintain effective financial controls and internal disclosures. The Company was forced to amend its 2018 annual report on Form 10-K restating its financial results for the third and fourth quarter of 2017. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Mattel investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 571554

Car Insurance Policies Available For US Drivers

LOS ANGELES, CA / ACCESSWIRE / December 28, 2019 / Compare-autoinsurance.org has launched a new blog post that presents several types of car insurance policies.

For more info and free online quotes, please visit https://compare-autoinsurance.org/insurance-options-available-for-u-s-drivers/.

Drivers that are living in the US have multiple choices for choosing the insurance policy they need. Besides the minimum required liability insurance that is imposed by each state, there are other types of insurance coverages that drivers might find them useful.

The most common car insurance options are the following:

Liability insurance. In most states, the law imposes the drivers to carry at least liability insurance. In case of a car accident, liability insurance will reimburse the costs of repairing the damaged property and the medical bills of the injured victims of an at-fault driver. Drivers not carrying this type of insurance will have to pay the costs for repairs and medical bills from their own pockets. Also, they will have to face the legal consequences of driving without having insurance.
Collision insurance. This coverage will pay to repair the policyholder's damaged vehicle. If the damaged vehicle is declared to be totaled, then the policyholder will be reimbursed with the actual value of his vehicle at the time of the accident. Drivers that own new or expensive vehicles should purchase collision insurance.
Comprehensive insurance. This policy will pay to repair or replace a damaged vehicle in an event that is not collision such as, fire, theft, flood, vandalism, etc. In most cases, this coverage will pay damages suffered due to things uncontrollable and unavoidable by the owner.
Personal injury protection. Also known as PIP, this insurance policy will provide coverage to the policyholder and his passengers. The costs of an accident can be quite high and in order to pay for the damage, drivers should acquire PIP insurance. This coverage will reimburse the medical bills of the policyholder and his passengers., no matter who is at-fault in a car accident.
Uninsured/Underinsured policy. It will pay for the policyholder and his passenger medical bills, lost wages, or other loses in the case the at-fault driver is not found, has no insurance, or has insufficient insurance to cover all the costs.

For additional info, money-saving tips and free car insurance quotes, visit https://compare-autoinsurance.org/.

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

"Besides the minimum required liability insurance that all drivers are required to purchase, there are other policies that can offer coverage in various situations," said Russell Rabichev, Marketing Director of Internet Marketing Company.

CONTACT:

Company Name: Internet Marketing Company
Person for contact Name: Gurgu C
Phone Number: (818) 359-3898
Email: cgurgu@internetmarketingcompany.biz
Website: https://compare-autoinsurance.org/

SOURCE: Internet Marketing Company

ReleaseID: 571540

Mxc Leverage and ETF Launch Simultaneously – Major Coins Is Booming

NEW YORK, NY / ACCESSWIRE / December 28, 2019 / Recently, MXC Exchange launched a leveraged ETF product – the 3x leverage Exchange Traded Fund (ETF) for BTC, ETH and EOS. Both long and short ones are available, and there is no forced liquidation. Crypto investors say "this is a product that will help users magnify their returns".

According to the statistics, most retail crypto investors have only small positions on major currencies in their investment portfolios. This is due to the fact that major currencies are typically less volatile than altcoins. Instead, some small projects with high potentials are more popular among retail investors because their price are more volatile. Therefore, the bad coins drive out good ones. Compared with mainstream currency, altcoins are more prone to market situations where commodities are overpriced and they can not be purchased.

Small circulating amount and pool underlying technologies are the defects of altcoins. Focusing on the latitude of "speculation", leveraged ETF can boost the development of mainstream currency while meeting the fluctuation demand and the utilization rate of its own funds (multiplied).

If someone is very confident about the market trend of mainstream currencies, they can use long or short ETF to gain profits.

Some users may already know something about leveraged ETF and some even have never heard of it. Next, MXC Exchange will explain in detail the use of ETF:

Now leveraged ETF on MXC Exchange supports the following products:

BTC3L/USDT、BTC3S/USDT、ETH3L/USDT、ETH3S/USDT、EOS3L/USDT、EOS3S/USDT。

BTC3L refers to 3-times buy (long) of BTC. The "L" here stands for "Long". In the same sense, BTC3S refers to 3-times sell (short) of BTC. The "S" here stands for "Short".

For example, if a user has bought BTC3L product, and the price of BTC (the underlying asset of BTC3L) now increases by 10%, then the leverage ETF product – BTC3L will correspondingly rise by 30%. On the contrary, if BTC falls by 10%, the BTC3L will also decreased by 30%.

In addition, BTC3S reversed ETF is also called "short ETF" or "bearish ETF". It provides the opposite performance of an index. Reverse ETF can also do 3-times leverage to amplify the performance caused by index drop. For example, if the price of BTC falls by 5%, then BTC3S will rise by 15%. If the price of BTC increases by 5%, BTC3S will falls by 15%.

Nevertheless, as for the primary investors with poor risk resistance, they should avoid using leverage and reverse ETF. If investors are confident in their judgment of market trends, such as the upgrade of Ethereum, the halving of bitcoin production, and the impact of Voice on EOS launch, leveraged ETF is a relatively practical tool.

In addition, unlike contract of high leverages, there is no forced liquidation for leveraged ETF products. There is a rebalancing system designed by the team of MXC Exchange. This system can adjust the investment portfolios for the leverage ETF products periodically to ensure the generally constant leverage times. Generally, the rebalance will be carried out in every 24 hours. Under special circumstances when price of the underlying asset undergoes great fluctuation which surpass the largest setting value (At the beginning, that is 15% for the losing side. In the future, the value may be different.), the team will carry out the rebalancing mechanism to control the risks of the investment portfolios.

The rebalancing mechanism is available for the losing side to protect the traders' interest. If the BTC rises by 15%, the rebalancing system will work for the trader of BTC3S product.

According to the ETF intraday price rise and fall calculation table provided by the rebalancing mechanism of MXC Exchange, the double opening of long and short positions may have the special effect of avoid risks or even making small profits:

For example, suppose people spend $100 for BTC3L, and $100 for BTC3S. When the BTC increases by 100%, their BTC3L will increases by 300% (that's $300). There is still remain $5.21 of their BTC3S product. After the deduction of the cost, people still earn $105.21. Though it is uncommon to witness the 100% gain of BTC, people cannot get rid of the possibility.

In general, when a bull market starts, people can also configure some leveraged ETF products since it will magnify user's returns and maximize the asset use rate, which are totally different from altcoins.

In 2019, the competition among exchanges are fiercer than before. However, MXC Exchange has established a good reputation in the industry with its high-quality services and smooth trading experience. In addition, the innovative launch of the leveraged ETF products for major currencies like BTC, ETH, and EOS directly meets the demand of large number of users.

Leveraged ETF is a product for both long-term and short-term investment of major currencies.

Organization: MXC PRO FOUNDATION LTD
Email: business@mxc.com

Lily
800-2365-8932
Website: www.mxc.com

SOURCE: MXC PRO FOUNDATION LTD

ReleaseID: 571542

Last-Minute FSA Purchases on the Rise for Family and Home Needs

Households Stock up on First Aid Kits for Family and Home Use

Woodbridge, United States – December 28, 2019 /MarketersMedia/

Around 30 million American households enrolled in Flexible Spending Account (FSA) are starting to choose which FSA-eligible items to purchase using their tax-exempt funds before the December 31, 2019, deadline.

FSAs are funds provided by employers to their employees through their individual savings accounts. These funds can be used to pay for healthcare services and purchases of medical items, tools, and even over-the-counter (OTC) medicines. Individuals enrolled in these benefits can stock their medicine cabinets with prescription medication, contact lenses, glasses, orthopedic aids, asthma inhalers, and other medical provisions such as first aid kits.

First aid kits are an essential item in every household. Families should ensure their kits are updated and stocked appropriately. This ensures that families can take care of minor injuries while allowing some flexibility in stabilizing more complex wounds.

Surviveware is sought after for their high-quality survival and preparedness gear, offering first-rate Small First Aid Kits that address the issues of households when it comes to emergency care.

The Surviveware Small First Aid Kit is compact and lightweight so that it fits into any bag, cupboard, cabinet, or glove compartment. Weighing only one pound, this life-saving kit is easy to carry and won’t weigh down parents who are out with their kids. Despite its size, this pack holds enough items to last through many excursions to the playground or camping ground.

It contains 100 of the most essential supplies for treating wounds and injuries sustained from home chores or playing in the backyard. The pack holds high-quality bandages, steri-strips, adhesives, and wraps. These are crucial provisions that can help patch up abrasions and scrapes sustained from rough play.

Apart from these supplies, the Small First Aid Kit also contains first aid tools such as tweezers, safety pins, trauma shears, splinter probes, triangular bandages, and a removable CPR Kit. This small kit also holds supplies for cleaning wounds and relieving insect bites.

To ensure that the kit can withstand constant wear and tear, it is made of 600D polyester. This material is water-resistant and helps to prevent moisture from ruining the medical provisions stored within. Since the kit is made of durable material, it won’t crack, break, or tear under pressure. It is also malleable enough to be crammed in one’s hiking pack without occupying too much space.

Surviveware’s Small First Aid Kit, which is available on Amazon Prime and can be purchased using FSA credit cards, has MOLLE-compatible snaps and straps to secure the kit on strollers, backpacks, and other hooks and bars throughout the home. It also hooks with a carabiner and squeezes perfectly inside a car glove compartment.

In a review written by a Surviveware Amazon customer, the reviewer shared his thoughts about owning a small first aid kit for home use:

“This is a great little product and has most of the essentials. The last few years, I have been doing first aid training and have learned a lot. This kit has everything in it for those basic skills that I have been taught.

I feel confident with this kit and my training to help those in need. I would highly recommend this for everyone to have in their vehicles or home emergency kits!”

Handle your FSA spending and home emergency care with ease by ordering a Surviveware Small First Aid Kit. Click here and grab your kit now!

Contact Info:
Name: Amanda Condry
Email: Send Email
Organization: Surviveware
Phone: 703-910-5188
Website: https://surviveware.com

Video URL: https://youtu.be/1fqvO3fYc8A

Source URL: https://marketersmedia.com/last-minute-fsa-purchases-on-the-rise-for-family-and-home-needs/88940771

Source: MarketersMedia

Release ID: 88940771

Plantronics Shareholder Notice: January 13, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser

SAN FRANCISCO, CA / ACCESSWIRE / December 28, 2019 / The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased or otherwise acquired the securities of Plantronics, Inc. ("Plantronics" or the "Company") (NYSE:PLT) between January 2, 2018 and November 5, 2019, inclusive (the "Class Period").

If you purchased or otherwise acquired Plantronics securities during the Class Period, you may move the Court for appointment as lead plaintiff by no later than January 13, 2020. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Your share of any recovery in the actions will not be affected by your decision of whether to seek appointment as lead plaintiff. You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.

Plantronics investors who wish to learn more about the litigation and how to seek appointment as lead plaintiff should click here or contact Sharon M. Lee of Lieff Cabraser toll-free at 1-800-541-7358.

Plantronics, incorporated in Delaware and headquartered in Santa Cruz, California, designs, manufactures, and markets integrated communications and collaboration solutions.

Plaintiffs allege that, throughout the Class Period, Plantronics made materially false or misleading statements, failing to disclose that (1) the Company had engaged in channel stuffing to artificially increase its sales; (2) the Company's internal controls over inventory levels were not effective; and (3) the Company had not adequately monitored inventory levels leading up to multiple product launches.

On November 5, 2019, Plantronics disclosed a $65 million reduction in channel inventory "by reducing sales to channel partners" and significantly lowered its fiscal 2020 guidance. The same day, Plantronics announced that the Executive Vice President of Global Sales, Jeff Loebbaka, was departing the Company. On that news, the price of Plantronics common stock fell $14.44 per share, or 36.61%, from a closing price of $39.44 on November 5, 2019, to close at $25.00 per share on November 6, 2019, on extremely elevated trading volume.

About Lieff Cabraser

Lieff Cabraser Heimann & Bernstein, LLP, with offices in San Francisco, New York, and Nashville, is a nationally recognized law firm committed to advancing the rights of investors and promoting corporate responsibility.

The National Law Journal has recognized Lieff Cabraser as one of the nation's top plaintiffs' law firms for fourteen years. In compiling the list, the National Law Journal examines recent verdicts and settlements and looked for firms "representing the best qualities of the plaintiffs' bar and that demonstrated unusual dedication and creativity." Law360 has selected Lieff Cabraser as one of the Top 50 law firms nationwide for litigation, highlighting our firm's "laser focus" and noting that our firm routinely finds itself "facing off against some of the largest and strongest defense law firms in the world." Benchmark Litigation has named Lieff Cabraser one of the "Top 10 Plaintiffs' Firms in America."

For more information about Lieff Cabraser and the firm's representation of investors, please visit https://www.lieffcabraser.com.

Follow us for updates on Twitter: https://twitter.com/LieffCabraser.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Source/Contact for Media Inquiries Only

Sharon M. Lee
Lieff Cabraser Heimann & Bernstein, LLP
Telephone: 1-800-541-7358

SOURCE: Lieff Cabraser Heimann & Bernstein, LLP

ReleaseID: 571526

5-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Sealed Air Corporation (SEE) Investors Who Suffered Significant Losses to Contact Firm, Application Deadline is Approaching

SAN FRANCISCO, CA / ACCESSWIRE / December 28, 2019 / Hagens Berman urges Sealed Air Corporation (NYSE:SEE) investors who have suffered significant losses to submit their losses now to learn if they qualify to recover their investment losses. The January 2, 2020 lead plaintiff deadline in a securities fraud class action that has been filed against the company and senior executives is fast approaching.

Class Period: Nov. 5, 2014 – Aug. 6, 2018
Lead Plaintiff Deadline: Jan. 2, 2020
Sign Up: www.hbsslaw.com/investor-fraud/SEE
Contact an Attorney Now: SEE@hbsslaw.com
844-916-0895
Sealed Air Corporation (SEE) Securities Class Action:

The complaint alleges that Defendants concealed that Sealed Air's deduction of $1.49 billion in connection with a settlement of asbestos liabilities was actually done for the improper purpose of artificially inflating the Company's financial results. Moreover, the complaint alleges that Sealed Air fired one auditor and hired another for an improper purpose – namely, to facilitate Defendants' efforts to engage in accounting fraud.

On August 6, 2018, Defendants revealed Sealed Air received a subpoena from the SEC concerning the Company's accounting for income taxes, financial reporting, and disclosures. This news drove the price of Sealed Air shares down $2.19, or down over 5%, on August 7, 2018.

Thereafter, on June 20, 2019, the Company fired CFO William Stiehl for cause after completing an internal investigation and receiving a second SEC subpoena.

If you invested in Sealed Air between Nov. 5, 2014 and Aug. 6, 2018 (the "Class Period") and suffered significant losses, you may qualify to be a lead plaintiff – one who selects and oversees the attorneys prosecuting the case. Contact Hagens Berman immediately for more information about the case and being a lead plaintiff.

"We're focused on recovering investors' substantial losses and holding Sealed Air and its senior management accountable for their alleged accounting fraud," said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you purchased shares of SEE and suffered significant losses, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Sealed Air should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email SEE@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:

Reed Kathrein, 844-916-0895

SOURCE: Hagens Berman Sobol Shapiro LLP

ReleaseID: 571036

HEXO Shareholder Notice: January 27, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser

SAN FRANCISCO, CA / ACCESSWIRE / December 28, 2019 / The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action litigation on behalf of investors who purchased or otherwise acquired the common stock of HEXO Corp. ("HEXO" or the "Company") (NYSE:HEXO) between January 25, 2019 and November 15, 2019, inclusive (the "Class Period").

If you purchased or otherwise acquired the common stock of HEXO during the Class Period, you may move the Court for appointment as lead plaintiff by no later than January 27, 2020. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Your share of any recovery in the actions will not be affected by your decision of whether to seek appointment as lead plaintiff. You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.

HEXO investors who wish to learn more about the litigation and how to seek appointment as lead plaintiff should click here or contact Sharon M. Lee of Lieff Cabraser toll-free at 1-800-541-7358.

HEXO, incorporated and headquartered in Canada, makes and sells cannabis products for distribution to users, principally through third-party physical and online retailers.

Based on our investigation, we believe HEXO made materially false or misleading statements by (1) providing revenue guidance that materially overstated HEXO's likely revenue for 2020, (2) overstating the number of retail locations for HEXO's product that would be available during the fiscal year of 2019, (3) overstating the value of inventory, and (4) failing to disclose the Company's unlicensed growth of cannabis in Niagara.

After the close of markets on October 4, 2019, HEXO announced the sudden resignation of its new Chief Financial Officer. In response, HEXO's stock price declined 6% to close at $3.80 on October 7, 2019, the next trading day.

Six days later on October 10, 2019, HEXO withdrew its revenue guidance for the fiscal year of 2020 based in part on slow expansion of retail locations in Quebec and Ontario. That day, HEXO's stock price closed at $3.66, or 22% lower than the prior day's closing price.

On October 28, 2019 HEXO announced that it would take an impairment charge as a result of an excess of inventory that was caused in part by the slow expansion of retail locations in Quebec and Ontario. HEXO's stock declined another 6% to close at $2.52 the next day.

Then on November 15, 2019, HEXO belatedly disclosed that it had identified the unlicensed growth of cannabis on a HEXO property on July 30, 2019. That day, HEXO's stock closed at $1.79, a 5% decline from the prior day's closing price.

About Lieff Cabraser

Lieff Cabraser Heimann & Bernstein, LLP, with offices in San Francisco, New York, and Nashville, is a nationally recognized law firm committed to advancing the rights of investors and promoting corporate responsibility.

The National Law Journal has recognized Lieff Cabraser as one of the nation's top plaintiffs' law firms for fourteen years. In compiling the list, the National Law Journal examines recent verdicts and settlements and looked for firms "representing the best qualities of the plaintiffs' bar and that demonstrated unusual dedication and creativity." Law360 has selected Lieff Cabraser as one of the Top 50 law firms nationwide for litigation, highlighting our firm's "laser focus" and noting that our firm routinely finds itself "facing off against some of the largest and strongest defense law firms in the world." Benchmark Litigation has named Lieff Cabraser one of the "Top 10 Plaintiffs' Firms in America."

For more information about Lieff Cabraser and the firm's representation of investors, please visit https://www.lieffcabraser.com/.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Source/Contact for Media Inquiries Only

Sharon M. Lee
Lieff Cabraser Heimann & Bernstein, LLP
Telephone: 1-800-541-7358

SOURCE: Lieff Cabraser Heimann & Bernstein, LLP

ReleaseID: 571524

Baxter Shareholder Notice: January 24, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser

SAN FRANCISCO, CA  / ACCESSWIRE / December 28, 2019 / The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased or otherwise acquired the securities of Baxter International Inc. ("Baxter" or the "Company") (NYSE:BAX) between February 21, 2019 and October 23, 2019, inclusive (the "Class Period").

If you purchased or otherwise acquired the securities of Baxter during the Class Period, you may move the Court for appointment as lead plaintiff by no later than January 24, 2020. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Your share of any recovery in the actions will not be affected by your decision of whether to seek appointment as lead plaintiff. You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.

Baxter investors who wish to learn more about the litigation and how to seek appointment as lead plaintiff should click here or contact Sharon M. Lee of Lieff Cabraser toll-free at 1-800-541-7358.

Background on the Baxter Securities Class Litigation

Baxter, based in Deerfield, Illinois, provides a broad portfolio of essential healthcare products, including acute chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, and surgical hemostat and sealant products.

The action alleges that during the Class Period, Baxter and certain of its officers made materially false and/or misleading statements and/or failed to disclose that: (i) certain intra-Company transactions, undertaken for the purpose of generating foreign exchange gains and losses, used foreign exchange rate conventions that were not in accordance with Generally Accepted Accounting Principles ("GAAP") and enabled intra-Company transactions to be undertaken after the related exchange rates were already known; 2) the Company lacked effective internal control over its financial reporting; (3) as a result, the Company's financial statements were misstated and would likely necessitate correction or amendment; (4) due to the Company's internal investigation, Baxter would not be able to timely file its quarterly report for the period ending September 30, 2019 with the Securities and Exchange Commission ("SEC") on Form 10-Q in a timely manner; and (5) as a result of the foregoing, Baxter and its officers' statements about the Company's business and operations lacked a reasonable basis at all relevant times.

On October 24, 2019, Baxter announced that it "recently began an investigation into certain intra-Company transactions undertaken for the purpose of generating foreign exchange gains or losses," and that according to the Company, "[t]hese transactions used a foreign exchange rate convention historically applied by the Company that was not in accordance with generally accepted accounting principles ("GAAP") and enabled intra-Company transactions to be undertaken after the related exchange rates were already known." The Company also admitted that these intra-Company transactions had "resulted in certain misstatements in the Company's previously reported non-operating income related to net foreign exchange gains" and acknowledged that upon completion of its investigation, "the Company expects to either amend its periodic reports previously filed with the SEC to include restated financial statements that correct those misstatements, or include in reports for future periods restated comparative financial statements that correct those misstatements." Following this news, the price of Baxter common stock fell $8.87 per share, or 10.1%, from a close of $87.95 per share on October 23, 2019 to close at $79.08 per share on October 24, 2019, on elevated trading volume.

About Lieff Cabraser

Lieff Cabraser Heimann & Bernstein, LLP, with offices in San Francisco, New York, and Nashville, is a nationally recognized law firm committed to advancing the rights of investors and promoting corporate responsibility.

The National Law Journal has recognized Lieff Cabraser as one of the nation's top plaintiffs' law firms for fourteen years. In compiling the list, the National Law Journal examines recent verdicts and settlements and looked for firms "representing the best qualities of the plaintiffs' bar and that demonstrated unusual dedication and creativity." Law360 has selected Lieff Cabraser as one of the Top 50 law firms nationwide for litigation, highlighting our firm's "laser focus" and noting that our firm routinely finds itself "facing off against some of the largest and strongest defense law firms in the world." Benchmark Litigation has named Lieff Cabraser one of the "Top 10 Plaintiffs' Firms in America."

For more information about Lieff Cabraser and the firm's representation of investors, please visit https://www.lieffcabraser.com/.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Source/Contact for Media Inquiries Only

Sharon M. Lee
Lieff Cabraser Heimann & Bernstein, LLP
Telephone: 1-800-541-7358

SOURCE: Lieff Cabraser Heimann & Bernstein, LLP

ReleaseID: 571523